Advisory Board on Cancer, Infertility and Pregnancy

NCT04904263 | Unknown

• 1 other identifier: ABCIP
• Study Type: observational
• Target: 100
• Locations: 1 country
• Sites: 1

Brief Summary

The Advisory Board on Cancer, Infertility and Pregnancy provides a platform where physicians from all over the world can request recommendations regarding the medical care of pregnant women diagnosed with cancer or regarding fertility preservation. The platform will contain different national advisory boards, with their own coordinator and members, as well as an overarching international advisory board with an international coordinator and members from different national boards. To investigate the impact of this platform, a year after its launch, data regarding the incoming requests will be extracted from the website, as well as all recommendation letters.

Conditions

Cancer in Pregnancy; Fertility Preservation; Cancer; Pregnancy

Keywords

Cancer in Pregnancy; Fertility preservation

Outcome Measures

Primary Outcomes (1)

• The impact of an international advisory board on cancer in pregnancy

  To investigate the impact of this platform, a year after its launch, data regarding the incoming requests will be extracted from the website, as well as all recommendation letters. All requesting physicians will be asked to complete a survey including their experiences with the ABCIP, to what amount they followed the given recommendations and the outcomes of mother (and child)

  1 year

Eligibility Criteria

• Sex: female
• Healthy Volunteers: No
• Age Groups: Child (0-17), Adult (18-64), Older Adult (65+)
• Sampling Method: Non-Probability Sample

Study Population

Advice can be requested regarding all patients with cancer during pregnancy, questions regarding patients with a fertility wish after cancer diagnosis or questions regarding patients with a postpartum cancer diagnosis

You may qualify if:

• Pregnant women with a cancer diagnosis
• Women with a fertility related question after cancer diagnosis
• Postpartum cancer diagnosis
• Cancer treatment during pregnancy

Sponsors & Collaborators

• University Hospital, Gasthuisberg: lead
• Kom Op Tegen Kanker: collaborator
• European Research Council: collaborator

Study Sites (1)

UZ Gasthuisberg, Katholieke Universiteit Leuven

Leuven, 3000, Belgium

RECRUITING

Related Links

• Link to the ABCIP platform

MeSH Terms

Conditions

Neoplasms

Study Officials

• Frederic Amant, MD,PhD

  Universitaire Ziekenhuizen KU Leuven

  PRINCIPAL INVESTIGATOR

Central Study Contacts

Frederic Amant, MD,PhD

CONTACT

+32 16 344252; frederic.amant@uzleuven.be

Joosje Heimovaara, MD

CONTACT

+32 16 344252; joosje.heimovaara@uzleuven.be

Study Design

• Study Type: observational
• Observational Model: OTHER
• Time Perspective: OTHER
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Prof. dr. Amant

Study Record Dates

• First Submitted: May 22, 2021
• First Posted: May 27, 2021
• Study Start: May 22, 2021
• Primary Completion: May 22, 2024
• Study Completion: May 22, 2024
• Last Updated: May 27, 2021

Record last verified: 2021-05

Locations

BE (1)